Close
The UCL Translational Research Office (TRO) has the ability to provide end-to-end translation, supporting the development of early stage research from across UCL and its partner hospitals, into projects attractive for translational funding or further development in partnership with industry.
The Translational Research Group (TRG) are project leaders who use their experience to guide projects through their development.
"As experienced project leaders we look to establish credibility with our academics, help them scope the projects’ translational critical path, assist with internal and external networking to link to resources required, access funding and provide research project management services” - Pamela Tranter, Head of Translational Research Group
Learn more about the Translational Research Support services provided by the TRG
The Business and Innovation Group (B&IG) focus on the development of innovative approaches for the creation and management of strategic partnerships with industry and attract the kind of resources that only such external organisations can provide.
"The mix of expertise that currently resides within the B&IG and the wider TRO has grown in response to the changing external environment… The pharma industry has significantly reorganised, cutting back on internal research to free-up resource to fund more open innovation and collaborative science. The Eisai/UCL collaboration is an excellent example of harnessing the capabilities of two organisations to truly accelerate drug development for patient benefit.” – Maryam Atakhorrami, former Head of the Business and Innovation Group.
Learn more about partnership support offered to Academics and Industry, through the B&IG
The whole UCL TRO team have a proven track record of therapeutic delivery and work in partnership with academics and industry partners, enhancing projects to optimise the chances of long-term success and benefit to patients. Contact us to find out how we can help to accelerate translation in your research.